IBISWorld Platform
Answer any industry question in minutes with our entire database at your fingertips.
Roche Products Pty Limited
Roche Products is a Proprietary Company that generates the majority of its income from the Pharmaceuticals Wholesaling industry. In 2024 the company generated total revenue of $637,449,000 including sales and other revenue. In 2024 Roche Products had 299 employees including employees from all subsidiaries under the company's control. The Chief Executive of Roche Products is Mr Stuart Knight whose official title is General Manager. The Chairman of Roche Products is either not applicable or not available. Roche Products Pty Ltd is primarily involved in the distribution of pharmaceuticals. Roche operates across Australia under three divisions: Pharmaceuticals - Roche Pharmaceuticals, based in Sydney, is engaged in the sale a range of differentiated prescription medicines and local pharmaceutical research and development. Research disease areas include anaemia, antiviral, autoimmune disorders, central nervous, miscellaneous, oncology, dermatology, and transplant. Diagnostics - Roche Diagnostics, based in North Ryde, is engaged in the sale of laboratory equipment, molecular testing devices, anatomical pathology readers, point-of-care instrumentation, genome sequencing products and prenatal testing products. Diabetes Care - Roche Diabetes Care, based in Bella Vista, is engaged in the provision of diabetes care products, technologies and services under its brand Accu-Check. Its products include meter systems, lancing devices, insulin delivery system, infusion sets and diabetes management software. Roche Diabetes Care also provides their patients mobile diabetes management app mySugr for self-monitoring.
Access this data your way
The Roche Products Pty Limited Industry analysis is available in multiple formats to fit seamlessly into your workflow.
API Data Delivery
Feed trusted, human-driven industry intelligence straight into your platform.
Integrations
Streamline your workflow with IBISWorld’s intelligence built into your toolkit.
What's included in this industry analysis
IBISWorld's research coverage on the Roche Products Pty Limited includes market sizing, forecasting, data and analysis. The most recent publication will be as current as of March 2026.
Company Details
What’s this enterprise profile about?
Roche Products Pty Limited, trading as Roche Products, operates under the ABN 70 000 132 865 and was incorporated on 03 June 1954. Roche Products Pty Limited primarily operates in the Pharmaceuticals Wholesaling industry in Australia.
Key Personnel
What’s included in the Key Personnel chapter?
The Key Personnel chapter outlines the principal leadership positions within Roche Products Pty Limited, including the Chairman, Board members, Chief Executive Officer, and other key management personnel. It provides an overview of the company’s governance and executive structure, along with a breakdown of gender diversity across leadership roles, offering insight into the composition of the organisation’s senior team.
Financials
What’s included in the Financials chapter?
The Financials chapter presents Roche Products Pty Limited’s historical financial performance, including detailed profit and loss statements outlining sales revenue, cost of sales, and profitability. It also incorporates balance sheet data, providing a breakdown of assets and liabilities, as well as additional financial metrics such as the number of shares on issue. Together, these disclosures offer a comprehensive view of the company’s financial position and performance over time.
Growth & Ratios
What’s included in the Growth & Rations chapter?
The Growth & Ratios chapter provides historical data on key financial performance indicators, enabling an assessment of the company’s operational efficiency, profitability, and financial structure over time. Metrics covered include return on equity, return on assets, profit margins, revenue per employee, as well as gearing and leverage ratios, offering a comprehensive view of performance trends and capital management.
Operating Segments
What’s included in the Operating Segments chapter?
The Operating Segments chapter provides an overview of the revenue composition and asset allocation across the various industries in which Roche Products Pty Limited operates. It offers insights into how the company’s financial performance is distributed among its core business segments, highlighting the relative contribution of each industry to total revenue.
Competitor Benchmarking
What’s included in the Competitor Benchmarking chapter?
The Competitor Benchmarking chapter includes a comparative assessment of Roche Products Pty Limited’s key financial, growth, and valuation ratios against industry averages to evaluate its competitive position. It analyses valuation metrics such as price-to-earnings, price-to-book, enterprise value to EBITDA, and enterprise value to sales, alongside core financial indicators including liquidity ratios and profitability measures.
Industries of Operation
What’s included in the Industries of Operation chapter?
The Industries of Operation chapter outlines Roche Products Pty Limited’s market share across the industries in which it operates. Each industry profile includes a comprehensive overview featuring data on total market size, the number of enterprises, industry concentration levels, and overall turnover. This analysis provides context for the company’s competitive position and scale within each relevant market.
Shareholders
What’s included in the Shareholders chapter?
The Shareholders chapter provides a breakdown of the ownership structure of Roche Products Pty Limited, identifying key shareholders and outlining their respective ownership interests. This section offers insight into the concentration of shareholdings, the presence of institutional or strategic investors, and the overall distribution of equity within the company.
Subsidiaries
What’s included in the Subsidiaries chapter?
The Subsidiaries chapter provides an overview of the companies and business entities that are wholly or partially owned by Roche Products Pty Limited. It outlines the ownership structure of each subsidiary, offering insight into the broader corporate group and how these entities contribute to the company’s overall activities and performance.
History
What’s included in the History chapter?
The History chapter presents a overview of Roche Products Pty Limited’s development, highlighting key milestones and significant corporate events since its incorporation. It includes the company’s incorporation date and outlines major strategic, operational, and structural developments, providing context for its evolution and current market position.
Trusted by industry professionals
More than 6,000 businesses use IBISWorld to shape local and global economies
We were able to supplement our reports with IBISWorld’s information from both a qualitative and quantitative standpoint. All of our reporting now features some level of IBISWorld integration.
IBISWorld delivers the crisp business knowledge we need to drive our business. Whether it be serving up our major clients, winning new business or educating on industry issues, IBISWorld brings real value.
IBISWorld has revolutionised business information — which has proved commercially invaluable to exporters, investors and public policy professionals in Australia and overseas.
When you’re able to speak to clients and be knowledgeable about what they do and the state that they operate in, they’re going to trust you a lot more.
Frequently Asked Questions
What is Roche Products Pty Limited?
Roche Products Pty Ltd is primarily involved in the distribution of pharmaceuticals. Roche operates across Australia under three divisions: Pharmaceuticals - Roche Pharmaceuticals, based in Sydney, is engaged in the sale a range of differentiated prescription medicines and local pharmaceutical research and development. Research disease areas include anaemia, antiviral, autoimmune disorders, central nervous, miscellaneous, oncology, dermatology, and transplant. Diagnostics - Roche Diagnostics, based in North Ryde, is engaged in the sale of laboratory equipment, molecular testing devices, anatomical pathology readers, point-of-care instrumentation, genome sequencing products and prenatal testing products. Diabetes Care - Roche Diabetes Care, based in Bella Vista, is engaged in the provision of diabetes care products, technologies and services under its brand Accu-Check. Its products include meter systems, lancing devices, insulin delivery system, infusion sets and diabetes management software. Roche Diabetes Care also provides their patients mobile diabetes management app mySugr for self-monitoring.
What industry does Roche Products Pty Limited operate in?
Roche Products Pty Limited, trading as Roche Products, is a Private Company that generates the majority of its income from the Pharmaceuticals Wholesaling industry in Australia.
Where is Roche Products Pty Limited located?
Murray Cod Australia Limited company is based at 30-34 Hickson Road, Sydney, New South Wales, Australia.
Who is the CEO of Roche Products Pty Limited?
The General Manager of Roche Products Pty Limited is Not Available and the General Manager is Stuart Knight.
What was Roche Products Pty Limited’s revenue in 2025?
In 2025, Roche Products Pty Limited generated total revenue of approximately $637.4 million.
Cut through the noise with intelligence you can trust
